PortalsOS

Three weeks later, I see in the press that Johnson & Johnson is about to get priority review by the agency for chemotherapy in the bladder.

Dr. Fagenbaum's discovery of a drug that saved his life led him to wonder how many other drugs could treat more diseases. He believes there are hidden cures in existing medications.

The FDA keeps telling you, no, no, no, not unless you do these trials. So I don't know in our lifetime, will we get... So are we going to avoid ovarian cancer? Are we going to avoid triple negative breast cancer? Are we going to avoid pancreatic cancer?

The drug Cerolimus, originally for organ transplant rejection, has kept Dr. Fagenbaum in remission for over 11 years.

It's a platform. It's not a, you know, one shot, you come in, you go to CVS, and you go home. What's in this injection is your body and my body is creating a protein called IL-15, into Leukin-15, some medical terms.

Dr. Fagenbaum's nonprofit aims to ensure that all FDA-approved drugs are used for every disease they can possibly treat.

The FDA refused to file our data for bladder cancer treatment, even though we have patients alive and cancer-free for 10 years. It's mystifying!

The success of Cerolimus in treating Dr. Fagenbaum's condition led him to wonder how many other existing drugs could treat different diseases, sparking the idea for EveryCure.

The story of Michael, a patient with metastatic angiosarcoma who benefited from a repurposed drug, illustrates the life-changing potential of drug repurposing.

The review process took two and a half years. It just got approved. This is why I said this president, and you and I talked about it, in his presidency could inform the world and the FDA that there's a breakthrough for all tumor types.